AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 251 filers reported holding AVANOS MED INC in Q3 2023. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $340,960 | +17.1% | 16,865 | +48.0% | 0.00% | 0.0% |
| Q2 2023 | $291,151 | -7.0% | 11,393 | +8.3% | 0.00% | 0.0% |
| Q1 2023 | $312,918 | +29.1% | 10,523 | +17.1% | 0.00% | – |
| Q4 2022 | $242,399 | +59.5% | 8,984 | +28.6% | 0.00% | – |
| Q3 2022 | $152,000 | -30.3% | 6,985 | -12.7% | 0.00% | – |
| Q2 2022 | $218,000 | -74.6% | 8,003 | -69.2% | 0.00% | -100.0% |
| Q1 2022 | $859,000 | +209.0% | 26,025 | +224.7% | 0.00% | +100.0% |
| Q4 2021 | $278,000 | +36.9% | 8,014 | +23.5% | 0.00% | – |
| Q3 2021 | $203,000 | +35.3% | 6,491 | +58.1% | 0.00% | – |
| Q2 2021 | $150,000 | -18.0% | 4,105 | -2.1% | 0.00% | – |
| Q1 2021 | $183,000 | -9.9% | 4,194 | -6.0% | 0.00% | -100.0% |
| Q4 2020 | $203,000 | +26.9% | 4,464 | -7.3% | 0.00% | – |
| Q3 2020 | $160,000 | -12.1% | 4,814 | -22.4% | 0.00% | -100.0% |
| Q2 2020 | $182,000 | +34.8% | 6,203 | -92.7% | 0.00% | 0.0% |
| Q1 2020 | $135,000 | – | 85,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |